ESSA Pharma Inc.·4/A

Jan 26, 7:02 PM ET

Glickman Richard M 4/A

4/A · ESSA Pharma Inc. · Filed Jan 26, 2021

Insider Transaction Report

Form 4/AAmended
Period: 2020-12-11
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-11+25,00025,000 total
    Exercise: $7.00Exp: 2030-12-11Common Shares (25,000 underlying)
Footnotes (1)
  • [F1]Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION